PRODUCTS & SERVICES
Grifols product portfolio
Since 1909, Grifols has been dedicated to developing high-quality products and services that enhance the health and well-being of people worldwide. We are committed to listening to and learning from our clients to ensure that their patients receive the best possible treatments.
Our ongoing R+D+i efforts enable us to offer a broad portfolio of innovative products and services.
Consult here our product catalog:
Select your country or region
- Czech Republic
- Hong Kong SAR
- Nordic Countries
- Taiwan, China
- United Kingdom
- United States
The product information for this country is also available in other languages. Please, Select your preferred language:
- Immunology and Neurology
- Intensive care
- Inclusiv Compounding Portfolio
- Robotics and other compounding devices
Learn more about our business:
Research, development, production and marketing of plasma-derived medicines and other innovative biopharmaceutical solutions to treat patients with chronic, rare and prevalent diseases that can be life-threatening. Key products include immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and specialty hyperimmune globulins.
Specialized in the research, development, production and commercialization of diagnostic products that span the healthcare continuum – from prevention, screening, diagnosis and prognosis to disease and treatment monitoring – to serve professionals working in transfusion medicine and clinical diagnostics.
Supplying high-quality biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products.